Neon Therapeutics

This page shows the latest Neon Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Newly-listed BioNTech buys Neon to boost cell therapy assets

German biotech has agreed to pay $67m in the deal. Just weeks after its $150m initial public offering, German biotech BioNTech has acquired troubled US counterpart Neon Therapeutics, adding to its ... BioNTech also gets rights to Neon’s

Latest news

After December slump, what’s in store for biotech in 2019?

Healthcare companies also featured among the worst performers however, including Genprex, Menlo and Neon Therapeutics which all suffered steep declines after their debuts.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Cancer immunotherapy: What's on the horizon?

article – but, as recent experience with Incyte and Nektar Therapeutics has shown, not all new drugs and combinations will succeed. ... Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

US biotech Translate Bio appoints Daniella Beckman

Beckman has over 15 years’ of financial and operational experience and she currently provides consulting and interim chief financial officer services for early-stage biotech companies, including Tango Therapeutics and Neon ... Therapeutics. She said:
Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

Hugh O'Dowd, chief executive officer of Neon Therapeutics said the company was privileged to have Dr Gaynor join its team. ... His knowledge and leadership reinforces Neon Therapeutics' leadership in neoantigen-based immuno-oncology treatments.”.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Associate Account Director: Competitive Salary

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Content Editor - Biotechnology: Salary TBC

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Account Manager: Competitive Salary

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Medical Writer: Competitive Salary

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Senior Account Executive: Competitive Salary

Medical Editor: Competitive Salary

PMHub

Add my company

dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?: Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
Empowering patients empowers results: Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials: What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...